{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:09:29Z","timestamp":1773698969132,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID\u201019's second wave had a significant impact on India, on May 7, 2021, the largest daily recorded case count was a little more than 4 million, and it has since fallen. Although the number of new cases reported has dropped, during the third week of May 2021, India accounted for about 45% of new cases identified globally and around 34% of deaths. As India maintains its present level of stability, a new urgent threat has emerged in the form of coronavirus\u2010associated mucormycosis. Mucormycosis, an acute and deadly fungal infection caused by Mucorales\u2010related fungal species, is a fungal emergency with a particularly aggressive propensity for contiguous spread, associated with a poor prognosis if not properly and immediately identified, and treated. Mucormycosis, sometimes referred to as the \u201cblack fungus,\u201d has increased more rapidly in India during the second wave of COVID\u201019 than during the first wave, with at least 14,872 cases as of May 28, 2021. Uncontrolled diabetic mellitus (DM) and other immunosuppressive diseases such as neutropenia and corticosteroid treatment have traditionally been identified as risk factors for mucormycosis. Therefore, the use of glucocorticoids or high doses of glucocorticoids in mild COVID\u201019 cases (without hypoxemia) should be avoided. In addition, drugs that target the immune pathway, such as tocilizumab, are not recommended without clear benefits.<\/jats:p>","DOI":"10.1002\/ddr.21862","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T08:00:03Z","timestamp":1627545603000},"page":"880-882","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Emerging cases of mucormycosis under <scp>COVID<\/scp>\u201019 pandemic in India: Misuse of antibiotics"],"prefix":"10.1002","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-0229","authenticated-orcid":false,"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[{"name":"School of Pharmacy Suresh Gyan Vihar University  Jaipur India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"S.","sequence":"additional","affiliation":[{"name":"Deccan School of Pharmacy Osmania University  Hyderabad India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Maharishi Arvind College of Pharmacy Ambabari Circle  Jaipur India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Thangavelu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical Sciences Saveetha University  Chennai India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences Lovely Professional University  Phagwara Punjab India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences Maharshi Dayanand University  Rohtak India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Pharmacy International Medical University  Kuala Lumpur Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[{"name":"Discipline of Pharmacy, Graduate School of Health University of Technology Sydney  Ultimo New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13256"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101174118"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590716"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1238"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26691"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.06.067"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab201"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-00873-9"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241663"},{"key":"e_1_2_4_12_1","first-page":"1","article-title":"Title of the article: Paranasal Mucormycosis in COVID\u201019 patient","author":"Saldanha M.","year":"2021","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00472-7"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3763_20"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_297_21"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3774_20"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13466"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00462-9"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21862","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ddr.21862","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.21862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:06:18Z","timestamp":1760439978000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.21862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1002\/ddr.21862"],"URL":"https:\/\/doi.org\/10.1002\/ddr.21862","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"2021-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}